- Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
- Annexon Reports First Quarter 2024 Financial Results and Key Anticipated Milestones
- Annexon Biosciences to Present at the Bank of America Health Care Conference
- Annexon Presents New Neuroprotection Data Showing ANX007 Protects Vision and Vision-Associated Structures in Geographic Atrophy at ARVO 2024 Annual Meeting
- Annexon to Present Data Reinforcing the Neuroprotective Effects of ANX007 and C1q Inhibition in Geographic Atrophy at the ARVO 2024 Annual Meeting
- Annexon Biosciences to Present at the 23rd Annual Needham Virtual Healthcare Conference
- Annexon Reports Fourth Quarter and Year-End 2023 Financial Results and Key Anticipated Milestones
- Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
- Annexon Biosciences to Present at the TD Cowen 44th Annual Health Care Conference
- Annexon to Host Virtual R&D Day on Guillain-Barré Syndrome, Focusing on its Serious Unmet Need and Annexon’s Novel Therapeutic Approach
More ▼
Key statistics
On Friday, Annexon Inc (ANNX:NSQ) closed at 4.33, 175.80% above the 52 week low of 1.57 set on Oct 16, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.41 |
---|---|
High | 4.45 |
Low | 4.20 |
Bid | 4.34 |
Offer | 4.39 |
Previous close | 4.36 |
Average volume | 1.85m |
---|---|
Shares outstanding | 92.41m |
Free float | 84.60m |
P/E (TTM) | -- |
Market cap | 400.15m USD |
EPS (TTM) | -1.46 USD |
Data delayed at least 15 minutes, as of May 17 2024 21:00 BST.
More ▼